{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:50:57Z","timestamp":1777521057297,"version":"3.51.4"},"reference-count":54,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:p>The pharmacotherapy of schizophrenia remains an ongoing challenge for researchers and clinicians alike. Current medications remain suboptimal to effectively treat this illness despite the recent surge of what are considered to be better antipsychotics: the atypicals. The atypicals cause fewer extrapyramidal symptoms and tardive dyskinesia, but there is growing concern regarding the significant long-term metabolic and cardiac adverse effects of these novel antipsychotics. There are differences among the atypicals in their propensity to produce these adverse effects, and clinicians should weigh the risk\u2013benefit ratio for each drug with each individual patient. Diabetes, heart disease, obesity, and unhealthy lifestyle choices are on the rise in the general population, and individuals with chronic schizophrenia are even more at risk. The dilemma clinicians face in trying to avoid the neurological morbidity of the typicals (extrapyramidal side effects and tardive dyskinesia) is the risk of consequently exposing patients to both the morbidity and potential mortality of the atypicals (cardiovascular, endocrine, and metabolic adverse effects). The importance of baseline investigations and monitoring at regular intervals as well as identification of patients at risk for obesity, diabetes, and cardiovascular morbidity has become crucial. Informed decision making is essential for successful antipsychotic pharmacotherapy. For a condition, which often necessitates long-term pharmacotherapy, the importance of prevention and (or) minimization of morbidity and mortality related to adverse effects of such pharmacotherapy cannot be understated.<\/jats:p>","DOI":"10.1177\/070674370304801107","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T16:28:09Z","timestamp":1484324889000},"page":"749-755","source":"Crossref","is-referenced-by-count":32,"title":["From Chlorpromazine to Clozapine\u2014Antipsychotic Adverse Effects and the Clinician's Dilemma"],"prefix":"10.1177","volume":"48","author":[{"given":"Sabina","family":"Abidi","sequence":"first","affiliation":[{"name":"Fourth-year Psychiatry Resident, Dalhousie University, Halifax, Nova Scotia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenivasa M","family":"Bhaskara","sequence":"additional","affiliation":[{"name":"Assistant Professor, Dalhousie University, Halifax, Nova Scotia; Staff Psychiatrist, Bedford\/Sackville Mental Health, Lower Sackville, Nova Scotia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"bibr1-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(98)00023-5"},{"key":"bibr2-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(05)70365-8"},{"key":"bibr3-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198808001-00010"},{"key":"bibr4-070674370304801107","first-page":"27","volume":"61","author":"Jests DV","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"bibr5-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199803003-00009"},{"key":"bibr6-070674370304801107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4088\/JCP.v61n0105","volume":"61","author":"Glazer WM","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"bibr7-070674370304801107","first-page":"445","volume":"29","author":"Keks N","year":"2000","journal-title":"How much better are they? Aust Fam Physician"},{"key":"bibr8-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800330013001"},{"key":"bibr9-070674370304801107","first-page":"31","volume":"60","author":"Stahl SM","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"bibr10-070674370304801107","volume-title":"Clozapine versus typical neuroleptic medication for schizophrenia (Cochrane review). Update software. Issue 1","author":"Wahlbeck K","year":"2002"},{"key":"bibr11-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.10.965"},{"key":"bibr12-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1018"},{"key":"bibr13-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7273.1371"},{"key":"bibr14-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00105-4"},{"key":"bibr15-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033333"},{"key":"bibr16-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000606"},{"issue":"9","key":"bibr17-070674370304801107","first-page":"25","volume":"63","author":"Meltzer HY","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"bibr18-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1007\/s002280100290"},{"key":"bibr19-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/53.17.2079"},{"key":"bibr20-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.6.975"},{"key":"bibr21-070674370304801107","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1109"},{"key":"bibr22-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00003"},{"key":"bibr23-070674370304801107","first-page":"382","volume":"15","author":"Ghaeli P","year":"1995","journal-title":"Pharmacotherapy"},{"issue":"4","key":"bibr24-070674370304801107","first-page":"56","volume":"63","author":"Macguire GA","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"bibr25-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80086-7"},{"key":"bibr26-070674370304801107","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0304"},{"key":"bibr27-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00100-0"},{"key":"bibr28-070674370304801107","volume-title":"Presented at the American College of NeuroPsychopharmacology Annual Meeting; December 12","author":"Wilson DR","year":"1999"},{"key":"bibr29-070674370304801107","volume-title":"Presented at the American College of Neurospychopharmacology; December 14","author":"Casey DE","year":"1999"},{"key":"bibr30-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.9.1471"},{"key":"bibr31-070674370304801107","first-page":"668","volume":"45","author":"Procyshyn RM","year":"2000","journal-title":"Can J Psychiatry"},{"key":"bibr32-070674370304801107","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0809f"},{"key":"bibr33-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.290"},{"key":"bibr34-070674370304801107","unstructured":"Bauer G. Diabetes and hypertension: A double whammy that needs urgent attention. The Medical Post Forum 2002(February):1\u20138."},{"key":"bibr35-070674370304801107","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0602"},{"key":"bibr36-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1686"},{"key":"bibr37-070674370304801107","first-page":"22","volume":"62","author":"Allison DB","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"bibr38-070674370304801107","unstructured":"National Heart, Lung and Blood Institute. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: Evidence report 2001. Available at http:\/\/www.nhibi.nih.gov\/guidelines\/obesity\/ob_gdlns.pdf."},{"key":"bibr39-070674370304801107","first-page":"360","volume":"61","author":"Blackburn GL","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"bibr40-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/68.4.899"},{"key":"bibr41-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.16.1530"},{"key":"bibr42-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801013380101"},{"key":"bibr43-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/63.3.419"},{"key":"bibr44-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a113240"},{"key":"bibr45-070674370304801107","first-page":"64","volume":"27","author":"Argenmyer MC","year":"2000","journal-title":"Psychiatr Praxis"},{"key":"bibr46-070674370304801107","first-page":"32","volume":"62","author":"Kurzthaler I","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"bibr47-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.67.5.968"},{"key":"bibr48-070674370304801107","unstructured":"Statistics Canada. 1998\u20131999. Catalogue number 82M0009XCB."},{"key":"bibr49-070674370304801107","first-page":"1039","volume":"166","author":"Katzmarzyk PT","year":"2002","journal-title":"CMAJ"},{"key":"bibr50-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.8.993"},{"key":"bibr51-070674370304801107","first-page":"10","volume":"60","author":"Goldman LS","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"bibr52-070674370304801107","doi-asserted-by":"publisher","DOI":"10.1177\/070674370304800412"},{"key":"bibr53-070674370304801107","first-page":"35","volume":"28","author":"Shonecker M.","year":"1957","journal-title":"Nemenarzt"},{"key":"bibr54-070674370304801107","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4088\/JCP.v62n0407","volume":"62","author":"Sussman N.","year":"2001","journal-title":"J Clin Psychiatry"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674370304801107","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/070674370304801107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:13:21Z","timestamp":1777392801000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/070674370304801107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1177\/070674370304801107"],"URL":"https:\/\/doi.org\/10.1177\/070674370304801107","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}